Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.

Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Cosford ND.

Brain Res. 2008 Oct 9;1234:16-24. doi: 10.1016/j.brainres.2008.07.063. Epub 2008 Jul 28.

PMID:
18692487
2.
3.

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents.

Lloyd GK, Menzaghi F, Bontempi B, Suto C, Siegel R, Akong M, Stauderman K, Velicelebi G, Johnson E, Harpold MM, Rao TS, Sacaan AI, Chavez-Noriega LE, Washburn MS, Vernier JM, Cosford ND, McDonald LA.

Life Sci. 1998;62(17-18):1601-6. Review.

PMID:
9585143
4.

TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.

Gatto GJ, Bohme GA, Caldwell WS, Letchworth SR, Traina VM, Obinu MC, Laville M, Reibaud M, Pradier L, Dunbar G, Bencherif M.

CNS Drug Rev. 2004 Summer;10(2):147-66. Review.

PMID:
15179444
5.

5-HT receptor regulation of neurotransmitter release.

Fink KB, Göthert M.

Pharmacol Rev. 2007 Dec;59(4):360-417. Review. Erratum in: Pharmacol Rev. 2008 Mar;60(1):142.

6.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Review.

PMID:
18761360
7.

ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders.

Rueter LE, Anderson DJ, Briggs CA, Donnelly-Roberts DL, Gintant GA, Gopalakrishnan M, Lin NH, Osinski MA, Reinhart GA, Buckley MJ, Martin RL, McDermott JS, Preusser LC, Seifert TR, Su Z, Cox BF, Decker MW, Sullivan JP.

CNS Drug Rev. 2004 Summer;10(2):167-82. Review.

PMID:
15179445
8.

The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control.

Decker MW, Meyer MD, Sullivan JP.

Expert Opin Investig Drugs. 2001 Oct;10(10):1819-30. Review.

PMID:
11772288
9.

A-85380: a pharmacological probe for the preclinical and clinical investigation of the alphabeta neuronal nicotinic acetylcholine receptor.

Rueter LE, Donnelly-Roberts DL, Curzon P, Briggs CA, Anderson DJ, Bitner RS.

CNS Drug Rev. 2006 Summer;12(2):100-12. Review.

PMID:
16958984
10.

Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development.

Janhunen S, Ahtee L.

Neurosci Biobehav Rev. 2007;31(3):287-314. Epub 2006 Dec 4. Review.

PMID:
17141870
11.

Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex.

Del Arco A, Mora F.

Pharmacol Biochem Behav. 2008 Aug;90(2):226-35. doi: 10.1016/j.pbb.2008.04.011. Epub 2008 Apr 23. Review.

PMID:
18508116
12.

Development of an adenoviral vector for intracerebral delivery of the dopamine D(2) receptor.

Ingram DK, Roth GS, Umegaki H, Ikari H.

Mech Ageing Dev. 2000 Jul 31;116(2-3):77-93. Review.

PMID:
10996008
13.

[Pharmacological role of isatin, an endogenous MAO inhibitor].

Hamaue N.

Yakugaku Zasshi. 2000 Apr;120(4):352-62. Review. Japanese.

PMID:
10774257
14.

Dopamine, serotonin and tachykinin in self-injurious behavior.

Sivam SP.

Life Sci. 1996 May 24;58(26):2367-75. Review.

PMID:
8691981
15.

CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor.

Trabace L, Cassano T, Loverre A, Steardo L, Cuomo V.

CNS Drug Rev. 2002 Spring;8(1):53-69. Review.

PMID:
12070526
16.

Identification and synthesis of novel alkaloids from the root system of Nicotiana tabacum: affinity for neuronal nicotinic acetylcholine receptors.

Wei X, Sumithran SP, Deaciuc AG, Burton HR, Bush LP, Dwoskin LP, Crooks PA.

Life Sci. 2005 Dec 22;78(5):495-505. Epub 2005 Sep 28. Review.

PMID:
16197964
17.

Multiple mechanisms of action: the pharmacological profile of budipine.

Eltze M.

J Neural Transm Suppl. 1999;56:83-105. Review.

PMID:
10370904
18.

Acetylcholine release from the central nervous system: a 50-year retrospective.

Phillis JW.

Crit Rev Neurobiol. 2005;17(3-4):161-217. Review.

PMID:
17341198
19.

Role of acetylcholine in neurotransmission of the carotid body.

Shirahata M, Balbir A, Otsubo T, Fitzgerald RS.

Respir Physiol Neurobiol. 2007 Jul 1;157(1):93-105. Epub 2007 Jan 11. Review.

PMID:
17284361
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk